Welcome to Week 5 of Hot Hormone Summer!
So far we’ve covered andropause (Week 1), menopause (Week 2), pre- and perimenopause (Week 3), and PCOS (Week 4). Today, Dr. Ramsey explains a crucial distinction in hormone therapy: bioidentical versus synthetic hormones and why that difference matters for outcomes and safety.
The Background
Early hormone replacement therapies were developed from non-human sources and synthetic compounds. A well-known example is Premarin, an estrogen product derived from pregnant mares’ urine. While Premarin contains some human-identical components, much of it is equine (horse) estrogen which is biologically different from the estradiol our bodies naturally produce.
Why “Synthetic” and “Bioidentical” Aren’t the Same
-
Bioidentical hormones are molecularly identical to the hormones our bodies make (for example, estradiol and natural progesterone).
-
Synthetic hormones (or non-bioidentical compounds like certain progestins) bind to the same receptors but produce different downstream effects and those differences can change risk profiles and clinical results.
What the Research and Clinical Experience Show
-
Some older studies of synthetic estrogens and progestins linked those compounds to increased risks of blood clots, strokes, and heart events.
-
In contrast, research on bioidentical estradiol shows markedly different outcomes. Many studies report no increased risk for blood clots, strokes, or heart attacks when prescribing bioidentical estradiol in appropriate patients.
-
Synthetic progestins frequently negate estrogen’s cardiovascular and lipid benefits and have been associated with increased breast cancer risk. Bioidentical progesterone, however, tends to preserve estrogen’s benefits, improve sleep and mood, and appears to be safer regarding breast cancer risk.
Clinical Takeaway (Dr. Ramsey’s View)
The choice of hormone formulation matters. Bioidentical hormones work with the body’s natural receptors in a way that often improves symptoms (sleep, mood, metabolism) and protects long-term health while some synthetic options can blunt benefits or increase risks. For patients on older synthetic regimens (for example, Premarin or certain synthetic progestins), it’s reasonable to discuss bioidentical alternatives with your clinician.
The Bottom Line
Not all hormone replacement therapies are interchangeable. When possible, consider evidence and patient outcomes. Bioidentical estradiol and progesterone often offer better safety and symptom outcomes compared with older synthetic formulations.
Want to dive deeper into hormone choices, risks, and treatments your doctor may not have covered?